Who
Steven R. King
Officer
Company insider
Files Form 4 as: Chief of Sustainable Supply, Jaguar Health.
In numbers
- Trades disclosed
- 37
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Jun 2016
- Last trade
- 11 Dec 2025
- Last filed
- 21 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Dec 2025filed 21 Jan 2026 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code A | —11,740 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,740 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,740 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code A | —11,740 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code D | $72.0M3,600 at $20,000.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | $76K3,785 at $20.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,304 | filing |
| 17 May 2025filed 20 May 2025 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code M | —1 at $0.00 | filing |
| 17 May 2025filed 20 May 2025 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code M | —1 | filing |
| 31 Mar 2025filed 2 Apr 2025 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code P | $72.0M3,600 at $20,000.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code P | —3,600 | filing |
| 8 Oct 2024filed 10 Oct 2024 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,376 at $0.00 | filing |
| 8 Oct 2024filed 10 Oct 2024 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code A | —4,922 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code M | —612 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code M | —612 | filing |
| 5 Apr 2024filed 17 Apr 2024 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —178 at $0.00 | filing |
| 5 Apr 2024filed 17 Apr 2024 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code M | —178 | filing |
| 14 Aug 2023filed 14 Aug 2023 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code A | —159,168 at $0.00 | filing |
| 17 May 2023filed 19 May 2023 | JAGX Jaguar Healthoption or derivative · Biotechnology | SEC FORM 4 Code M | —611 at $0.00 | filing |
| 17 May 2023filed 19 May 2023 | JAGX Jaguar HealthBiotechnology | SEC FORM 4 Code M | —611 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.